Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

AGM Statement and Board Appointment

28 May 2025 07:00

RNS Number : 2864K
Aptitude Software Group PLC
28 May 2025
 

28 May 2025 

Aptitude Software Group plc

("Aptitude" or the "Group")

AGM Statement and Board Appointment

Aptitude, (LSE: APTD), a market-leading provider of finance transformation software solutions, provides the following update in advance of the Annual General Meeting to be held at 9:30 a.m. today.

Highlights

· The Board remains confident that the Group's performance for 2025 will be in line with expectations, despite continued economic uncertainty, particularly in North America.

· Three new enterprise wins year to date for Fynapse, Aptitude's lead AI autonomous finance solution.

· Organisational transformation to partner-led model now substantially complete, providing the foundation to unlock the full value of the Fynapse opportunity.

· Continued cross-sell and up-sell successes, securing a number of renewals with existing clients.

· Appointment of Paula Dowdy as Non-Executive and Senior Independent Director.

AGM Statement

The Group has made positive progress to date in H1 2025, providing confidence in a successful performance in FY25, in line with the Board's expectations. The major organisational transformation to reposition Aptitude as a scalable, high-margin, SaaS-led, partner-first organisation is near completion. Structural changes across product, go-to-market, and client experience functions are now moving into execution and key global partners are engaged and active. This is expected to result in an improving contribution to pipeline and deal progression from partners and the Group remains focused on delivering 80% partner sourced ARR by 2027.

Fynapse continues to gain momentum in the market, supported by new enterprise wins, including a leading Australian payments provider, a global mobile parking platform provider and a major U.S. health insurer. These wins highlight Aptitude's expansion into the Tier 2 market and continued progress with Aptitude Accounting Hub Fynapse migrations.

While the macro-economic environment continues to have some impact on corporate decision making, particularly in North America, increasing partner engagement is driving an improved Fynapse pipeline. This is supported by continued renewals, cross-sell and up-sell successes with existing clients in the period, leading to an expanded footprint within the installed base, reinforcing the long-term opportunity for future Fynapse adoption.

Board Changes

The Board is pleased to announce the appointment of Paula Dowdy to the Board as Non-Executive Director, Senior Independent Director, and Chair of the Remuneration Committee, effective from the conclusion of today's AGM. Paula has more than 35 years of international leadership experience across technology, software, and services organisations. Paula brings a strong track record of leading major organisational change programmes, scaling commercial operations, and driving strong growth. Previous experience includes senior leadership roles at Cisco Systems, Inc. and Illumina, Inc and board positions at AVEVA Group plc (March 2019 - March 2023), and SPT Labtech (March 2023 - March 2025). Paula currently serves on the board of Quantum-Si, Inc (NASDAQ listed) and Sensio AS (private), and is based in the D.C. area, USA.

 

As previously announced, Barbara Moorhouse will step down from the Board following the conclusion of this year's AGM. Barbara has served as a Non-Executive Director since April 2017, and from March 2022, as Senior Independent Director and Chair of the Remuneration Committee.

Ivan Martin, Chairman of Aptitude, commented: "On behalf of the Board, I would like to extend my sincere thanks to Barbara for her insightful guidance, hard work and long-standing support over the past eight years.

"I am delighted to welcome Paula to the Board. Her significant expertise in SaaS, enterprise software, the U.S. market, and partner-led growth will be an invaluable support to Aptitude as we scale in our key markets and continue to execute against our ambition to be the leader in AI-powered finance transformation."

 

Incoming Non-Executive and Senior Independent Director Paula Dowdy commented: "I am incredibly excited to be joining the Board of Aptitude at what is a significant time for the business. With Fynapse, the ability to not only deliver value to customers but also drive organisational change for greater success through its AI-powered finance platform offers huge potential for businesses of any scale and in any industry. This opportunity, combined with Aptitude's strong leadership, strategic partnerships, and clear commercial strategy are attributes which attracted me to the business, and I'm eager to work with the teams to drive execution and growth."

 

There is no other information regarding Paula Dowdy's appointment to be disclosed under paragraph 6.4.8R of the UK Listing Rules.

 

 

For further information, please contact:

Aptitude Software Group plc

020-3687-3200

Alex Curran, Chief Executive Officer

Ivan Martin, Chairman

 

 

 

Canaccord Genuity Limited

020-7523-8000

Simon Bridges / Andrew Potts

 

 

 

Alma Strategic Communications

 

Caroline Forde / Hilary Buchanan / Will Ellis Hancock

020-3405-0205

 

About Aptitude Software

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally. Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPKOBQPBKDQPB
Date   Source Headline
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology
2nd May 201410:48 amRNSDirector/PDMR Shareholding
1st May 201410:28 amRNSTotal Voting Rights
28th Apr 201411:28 amRNSResult of AGM
28th Apr 20147:00 amRNSInterim Management Statement
16th Apr 20145:24 pmRNSDirector Declaration
7th Apr 201411:04 amRNSBlocklisting Interim Review
11th Mar 201411:29 amRNSPosting of Annual Report & AGM
26th Feb 20147:00 amRNSPreliminary Results
20th Feb 201410:25 amRNSNotice of Results
10th Feb 20144:24 pmRNSHolding(s) in Company
14th Jan 201410:14 amRNSHolding(s) in Company
3rd Jan 20143:56 pmRNSBlocklisting Interim Review
18th Dec 20135:14 pmRNSDirector/PDMR Shareholding
5th Dec 201310:33 amRNSHolding(s) in Company
4th Dec 20135:52 pmRNSHolding(s) in Company
4th Dec 20134:23 pmRNSHolding(s) in Company
4th Dec 20134:20 pmRNSHolding(s) in Company
4th Dec 20134:19 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSResult of Tender Offer
18th Nov 201311:52 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.